1. Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity. Issue 10 (3rd January 2008) Authors: Avouac, J; Juin, F; Wipff, J; Couraud, P O; Chiocchia, G; Kahan, A; Boileau, C; Uzan, G; Allanore, Y Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 10(2008) Page Start: 1455 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DI-057 Patients with chronic inflammatory rheumatism: evaluation of their knowledge on disease modifying antirheumatic drugs. (25th February 2017) Authors: Boissinot, L; Gutermann, L; Dormeuil, M; Trouvin, AP; Avouac, J; Chast, F; Conort, O Journal: European journal of hospital pharmacy Issue: Volume 24(2017)Supplement 1 Page Start: A138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Issue 7 (10th April 2006) Authors: Avouac, J; Gossec, L; Dougados, M Journal: Annals of the rheumatic diseases Issue: Volume 65:Issue 7(2006) Page Start: 845 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effects of oral treatments on exercise capacity in systemic sclerosis related pulmonary arterial hypertension: a meta-analysis of randomised controlled trials. Issue 6 (27th September 2007) Authors: Avouac, J; Wipff, J; Kahan, A; Allanore, Y Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 6(2008) Page Start: 808 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Enhanced expression of ephrins and thrombospondins in the dermis of patients with early diffuse systemic sclerosis. (9th March 2010) Authors: Avouac, J; Clemessy, M; Gasc, J M; Ruiz, B; Vacher-Lavenu, M C; Wipff, J; Kahan, A; Boileau, C; Corvol, P; Allanore, Y Journal: Annals of the rheumatic diseases Issue: Volume 69(2010)Supplement 2 Page Start: A64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Issue 5 (15th January 2009) Authors: Kowal-Bielecka, O; Landewé, R; Avouac, J; Chwiesko, S; Miniati, I; Czirjak, L; Clements, P; Denton, C; Farge, D; Fligelstone, K; Földvari, I; Furst, D E; Müller-Ladner, U; Seibold, J; Silver, R M; Takehara, K; Toth, B Garay; Tyndall, A; Valentini, G; van den Hoogen, F Journal: Annals of the rheumatic diseases Issue: Volume 68:Issue 5(2009) Page Start: 620 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells. Issue 2 (23rd July 2008) Authors: Distler, J H W; Allanore, Y; Avouac, J; Giacomelli, R; Guiducci, S; Moritz, F; Akhmetshina, A; Walker, U A; Gabrielli, A; Müller-Ladner, U; Tyndall, A; Matucci-Cerinic, M; Distler, O Journal: Annals of the rheumatic diseases Issue: Volume 68:Issue 2(2009) Page Start: 163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research. Issue 5 (28th October 2008) Authors: Avouac, J; Kowal-Bielecka, O; Landewe, R; Chwiesko, S; Miniati, I; Czirjak, L; Clements, P; Denton, C; Farge, D; Fligelstone, K; Földvari, I; Furst, D E; Müller-Ladner, U; Seibold, J; Silver, R M; Takehara, K; Toth, B Garay; Tyndall, A; Valentini, G; van den Hoogen, F Journal: Annals of the rheumatic diseases Issue: Volume 68:Issue 5(2009) Page Start: 629 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0390 European multicentre study validates elf test as biomarker of fibrosis in systemic sclerosis. (15th June 2017) Authors: Abignano, G; Blagojevic, J; Bissell, L-A; Dumitru, RB; Eng, S; Allanore, Y; Avouac, J; Bosello, S; Denton, C; Distler, O; Ferraccioli, G; Jordan, S; Matucci-Cerinic, M; Ong, V; Messenger, M; Hutchinson, M; Buch, MH; Emery, P; Galdo, F Del Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 635 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis. Issue 4 (13th December 2010) Authors: Dieudé, P; Guedj, M; Wipff, J; Ruiz, B; Riemekasten, G; Airo, P; Melchers, I; Hachulla, E; Cerinic, M Matucci; Diot, E; Hunzelmann, N; Caramaschi, P; Sibilia, J; Tiev, K; Mouthon, L; Riccieri, V; Cracowski, J L; Carpentier, P H; Distler, J; Amoura, Z Journal: Annals of the rheumatic diseases Issue: Volume 70:Issue 4(2011) Page Start: 668 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗